Christopher Kim, Chairman and CMO: Apimeds Pharmaceuticals US APUS Buy · Filed 25/05/15

Trade details

Type: Insider buy
Amount: $14,377.8
Shares · price: 7,730 sh · $1.86 a share
Held after: 27,500 sh
Stock: Apimeds Pharmaceuticals US APUS
Person: Christopher KimChairman and CMO
Trade date: 25/05/14
Filed: 25/05/15
Days to filing: 1 days

First buy since 2023

Insiders buying this week: 3 insiders
Holding change: +39.1%

Apimeds Pharmaceuticals US trades, last 26 weeks

What else happened in Apimeds Pharmaceuticals US around then

Filed or reported within 30 days of the trade day · 25/04/14~25/06/13

Christopher Kim's recent trades

Christopher KimChairman and CMO
BuyApimeds Pharmaceuticals US
Buy
Apimeds Pharmaceuticals US
APUS
$36K
19,770 sh
$36K
Filed 25/05/15
Traded 25/05/13

Christopher Kim, Chairman — bought $14.4K of Apimeds Pharmaceuticals US APUS · 7,730 sh @ $1.86 | Whalegun